Form 8-K - Current report:
SEC Accession No. 0001558370-21-000051
Filing Date
2021-01-06
Accepted
2021-01-06 16:05:44
Documents
6
Period of Report
2020-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20201231x8k.htm 8-K 72350
2 EX-2.1 tmb-20201231xex2d1.htm EX-2.1 677708
3 EX-10.1 tmb-20201231xex10d1.htm EX-10.1 75405
4 EX-10.2 tmb-20201231xex10d2.htm EX-10.2 35155
5 EX-99.1 tmb-20201231xex99d1.htm EX-99.1 23998
6 GRAPHIC tmb-20201231xex99d1001.jpg GRAPHIC 8320
  Complete submission text file 0001558370-21-000051.txt   897792
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 21510512
SIC: 2834 Pharmaceutical Preparations